DeVuono MV et al. |
Conditioned gaping produced by high dose Δ-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system. |
2018 |
Neuropharmacology |
pmid:30195587
|
Ratano P et al. |
Pharmacological inhibition of 2-arachidonoilglycerol hydrolysis enhances memory consolidation in rats through CB2 receptor activation and mTOR signaling modulation. |
2018 |
Neuropharmacology |
pmid:29842858
|
Shonesy BC et al. |
The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium. |
2015 |
Neuropharmacology |
pmid:25484252
|
Atwood BK et al. |
CBâ‚‚ cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons. |
2012 |
Neuropharmacology |
pmid:22579668
|
Pasquarelli N et al. |
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS. |
2017 |
Neuropharmacology |
pmid:28373073
|
Kortleven C et al. |
Neurotensin inhibits glutamate-mediated synaptic inputs onto ventral tegmental area dopamine neurons through the release of the endocannabinoid 2-AG. |
2012 |
Neuropharmacology |
pmid:22884466
|
Nader J et al. |
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors. |
2014 |
Neuropharmacology |
pmid:24709540
|
Hashimotodani Y et al. |
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. |
2008 |
Neuropharmacology |
pmid:17655882
|
Mátyás F et al. |
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area. |
2008 |
Neuropharmacology |
pmid:17655884
|
Pasquarelli N et al. |
Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue. |
2015 |
Neuropharmacology |
pmid:25497453
|
Morena M et al. |
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety. |
2016 |
Neuropharmacology |
pmid:27553121
|
Rubio M et al. |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. |
2008 |
Neuropharmacology |
pmid:18371990
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Desroches J et al. |
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CBâ‚ and CBâ‚‚ receptors. |
2014 |
Neuropharmacology |
pmid:24148808
|
Morgan NH et al. |
Functional CB2 type cannabinoid receptors at CNS synapses. |
2009 |
Neuropharmacology |
pmid:19616018
|
Wilkerson JL et al. |
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice. |
2017 |
Neuropharmacology |
pmid:27890602
|
Placzek EA et al. |
Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. |
2008 |
Neuropharmacology |
pmid:18760289
|
Covey DP et al. |
Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease. |
2018 |
Neuropsychopharmacology |
pmid:29925886
|
Wills KL et al. |
Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats. |
2016 |
Neuropsychopharmacology |
pmid:26647976
|
Viganò D et al. |
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain. |
2003 |
Neuropsychopharmacology |
pmid:12637958
|
Morena M et al. |
Enhancing Endocannabinoid Neurotransmission Augments The Efficacy of Extinction Training and Ameliorates Traumatic Stress-Induced Behavioral Alterations in Rats. |
2018 |
Neuropsychopharmacology |
pmid:29265107
|
Morena M et al. |
Neurobiological Interactions Between Stress and the Endocannabinoid System. |
2016 |
Neuropsychopharmacology |
pmid:26068727
|
Sumislawski JJ et al. |
Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. |
2011 |
Neuropsychopharmacology |
pmid:21849983
|
Dubreucq S et al. |
Genetic dissection of the role of cannabinoid type-1 receptors in the emotional consequences of repeated social stress in mice. |
2012 |
Neuropsychopharmacology |
pmid:22434220
|
Oleson EB et al. |
Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release. |
2014 |
Neuropsychopharmacology |
pmid:24345819
|
Sarchielli P et al. |
Endocannabinoids in chronic migraine: CSF findings suggest a system failure. |
2007 |
Neuropsychopharmacology |
pmid:17119542
|
Blasio A et al. |
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala. |
2013 |
Neuropsychopharmacology |
pmid:23793355
|
Patel S et al. |
Repeated homotypic stress elevates 2-arachidonoylglycerol levels and enhances short-term endocannabinoid signaling at inhibitory synapses in basolateral amygdala. |
2009 |
Neuropsychopharmacology |
pmid:19675536
|
Maccarrone M et al. |
Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. |
2010 |
Neuropsychopharmacology |
pmid:20393458
|
Lim J et al. |
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats. |
2016 |
Neuropsychopharmacology |
pmid:26361059
|
Cristino L et al. |
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency. |
2016 |
Neuropsychopharmacology |
pmid:26081302
|
Pérez-Morales M et al. |
2-Arachidonoylglycerol into the lateral hypothalamus improves reduced sleep in adult rats subjected to maternal separation. |
2014 |
Neuroreport |
pmid:25356522
|
Beltramo M and Piomelli D |
Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. |
2000 |
Neuroreport |
pmid:10817598
|
Rubio M et al. |
Short-term exposure to alcohol in rats affects brain levels of anandamide, other N-acylethanolamines and 2-arachidonoyl-glycerol. |
2007 |
Neurosci. Lett. |
pmid:17574742
|
Sinor AD et al. |
Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. |
2000 |
Neurosci. Lett. |
pmid:10653017
|
Sugiura T et al. |
Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. |
2001 |
Neurosci. Lett. |
pmid:11137756
|
Maison P et al. |
BDNF regulates neuronal sensitivity to endocannabinoids. |
2009 |
Neurosci. Lett. |
pmid:19818836
|
Urbanski MJ et al. |
Endocannabinoid-mediated synaptically evoked suppression of GABAergic transmission in the cerebellar cortex. |
2010 |
Neuroscience |
pmid:20553815
|
Zhang L et al. |
Endocannabinoid 2-AG and intracellular cannabinoid receptors modulate a low-threshold calcium spike-induced slow depolarizing afterpotential in rat thalamic paraventricular nucleus neurons. |
2016 |
Neuroscience |
pmid:26924019
|
Turunen PM et al. |
Endocannabinoid Signaling in Embryonic Neuronal Motility and Cell-Cell Contact - Role of mGluR5 and TRPC3 Channels. |
2018 |
Neuroscience |
pmid:29438802
|
Dowie MJ et al. |
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. |
2009 |
Neuroscience |
pmid:19524019
|
Straiker A and Mackie K |
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. |
2009 |
Neuroscience |
pmid:19501632
|
Pascual AC et al. |
2-Arachidonoylglycerol metabolism is differently modulated by oligomeric and fibrillar conformations of amyloid beta in synaptic terminals. |
2017 |
Neuroscience |
pmid:28844762
|
Roberts CJ et al. |
Swim stress differentially affects limbic contents of 2-arachidonoylglycerol and 2-oleoylglycerol. |
2012 |
Neuroscience |
pmid:22192839
|
Musella A et al. |
Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum. |
2010 |
Neuroscience |
pmid:20219639
|
Ludányi A et al. |
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. |
2011 |
Neuroscience |
pmid:21035522
|
Veeraraghavan P et al. |
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro. |
2016 |
Neuroscience |
pmid:27450568
|
Palkovits M et al. |
Regional distribution and effects of postmortal delay on endocannabinoid content of the human brain. |
2008 |
Neuroscience |
pmid:18343585
|
Yang W et al. |
Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells. |
2016 |
Neuroscience |
pmid:26621126
|
Chen X et al. |
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults. |
2011 |
Neuroscience |
pmid:21256197
|
Petrosino S et al. |
Alteration of the endocannabinoid system in mouse brain during prion disease. |
2011 |
Neuroscience |
pmid:21195746
|
Ikeda H et al. |
Activation of spinal cannabinoid CB2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. |
2013 |
Neuroscience |
pmid:23892011
|
Sticht MA et al. |
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats. |
2015 |
Neuroscience |
pmid:25499318
|
Palmer JA et al. |
Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse. |
2008 |
Neuroscience |
pmid:18541380
|
Hutch CR et al. |
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction. |
2015 |
Neuroscience |
pmid:26037800
|
Gopez JJ et al. |
Cyclooxygenase-2-specific inhibitor improves functional outcomes, provides neuroprotection, and reduces inflammation in a rat model of traumatic brain injury. |
2005 |
Neurosurgery |
pmid:15730585
|
Smaga I et al. |
Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures. |
2014 |
Neurotox Res |
pmid:24652522
|
Smaga I et al. |
Changes in the Brain Endocannabinoid System in Rat Models of Depression. |
2017 |
Neurotox Res |
pmid:28247204
|
Carr RL et al. |
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development. |
2017 |
Neurotoxicology |
pmid:26642910
|
Rademacher DJ et al. |
Waterborne lead exposure affects brain endocannabinoid content in male but not female fathead minnows (Pimephales promelas). |
2005 |
Neurotoxicology |
pmid:15527869
|
Liu J et al. |
Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum. |
2015 |
Neurotoxicology |
pmid:26215119
|
Tsuyama S et al. |
Dietary conjugated linoleic acid modifies the brain endocannabinoid system in mice. |
2009 |
Nutr Neurosci |
pmid:19622239
|
Haas MJ et al. |
Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids. |
2012 |
Obesity (Silver Spring) |
pmid:22016100
|
Gonthier MP et al. |
Identification of endocannabinoids and related compounds in human fat cells. |
2007 |
Obesity (Silver Spring) |
pmid:17426318
|
Starowicz KM et al. |
Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. |
2008 |
Obesity (Silver Spring) |
pmid:18239598
|
Zelber-Sagi S et al. |
Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease. |
2017 |
Obesity (Silver Spring) |
pmid:27863097
|
Abdulnour J et al. |
Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study. |
2014 |
Obesity (Silver Spring) |
pmid:23616305
|
Engeli S et al. |
Peripheral endocannabinoid system activity in patients treated with sibutramine. |
2008 |
Obesity (Silver Spring) |
pmid:18356837
|
Motaghedi R and McGraw TE |
The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. |
2008 |
Obesity (Silver Spring) |
pmid:18551116
|
Bernabò N et al. |
Systems biology analysis of the endocannabinoid system reveals a scale-free network with distinct roles for anandamide and 2-arachidonoylglycerol. |
2013 |
OMICS |
pmid:24117401
|
Echigo R et al. |
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells. |
2012 |
Oncol. Rep. |
pmid:22842590
|
Orellana-Serradell O et al. |
Proapoptotic effect of endocannabinoids in prostate cancer cells. |
2015 |
Oncol. Rep. |
pmid:25606819
|
Vujic N et al. |
Monoglyceride lipase deficiency affects hepatic cholesterol metabolism and lipid-dependent gut transit in ApoE-/- mice. |
2017 |
Oncotarget |
pmid:28380440
|
Rea K et al. |
Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats. |
2013 |
Pain |
pmid:23414578
|
Telleria-Diaz A et al. |
Spinal antinociceptive effects of cyclooxygenase inhibition during inflammation: Involvement of prostaglandins and endocannabinoids. |
2010 |
Pain |
pmid:19879047
|
Bradshaw H |
CB1-induced side effects of specific COX-2 inhibitors: a feature, not a bug. |
2010 |
Pain |
pmid:19913999
|
La Porta C et al. |
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain. |
2015 |
Pain |
pmid:26067584
|
Carloni S et al. |
Pretreatment with the monoacylglycerol lipase inhibitor URB602 protects from the long-term consequences of neonatal hypoxic-ischemic brain injury in rats. |
2012 |
Pediatr. Res. |
pmid:22821058
|
den Boon FS et al. |
Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex. |
2014 |
Pflugers Arch. |
pmid:24671573
|
Carrasquer A et al. |
Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor. |
2010 |
Pharmacogenet. Genomics |
pmid:20124950
|
Pérez-Morales M et al. |
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats. |
2013 |
Pharmacol. Biochem. Behav. |
pmid:23603032
|
Wakley AA and Rasmussen EB |
Effects of cannabinoid drugs on the reinforcing properties of food in gestationally undernourished rats. |
2009 |
Pharmacol. Biochem. Behav. |
pmid:19602424
|
Stanley CP and O'Sullivan SE |
Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries. |
2014 |
Pharmacol. Res. |
pmid:24548820
|
Eisenstein SA et al. |
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy. |
2010 |
Pharmacol. Res. |
pmid:20044005
|
Deshmukh RR and Sharma PL |
Stimulation of accumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats. |
2012 |
Pharmacol. Res. |
pmid:22728691
|
Khasabova IA et al. |
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy. |
2014 |
Pharmacol. Res. |
pmid:25304184
|
Navarria A et al. |
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis. |
2014 |
Pharmacol. Res. |
pmid:24861565
|
Spradley JM et al. |
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms. |
2010 |
Pharmacol. Res. |
pmid:20416378
|
Leishman E et al. |
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain. |
2016 |
Pharmacol. Res. |
pmid:27109320
|
Guindon J et al. |
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment. |
2013 |
Pharmacol. Res. |
pmid:23127915
|
Sciolino NR et al. |
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats. |
2011 |
Pharmacol. Res. |
pmid:21600985
|
Stefano GB et al. |
2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. |
2000 |
Pharmacol. Res. |
pmid:10987990
|
Malek N et al. |
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain. |
2016 |
Pharmacol. Res. |
pmid:27326920
|
Fowler CJ and Ghafouri N |
Does the hydrolysis of 2-arachidonoylglycerol regulate its cellular uptake? |
2008 |
Pharmacol. Res. |
pmid:18675915
|
Nicolussi S et al. |
Guineensine is a novel inhibitor of endocannabinoid uptake showing cannabimimetic behavioral effects in BALB/c mice. |
2014 |
Pharmacol. Res. |
pmid:24412246
|
Khasabova IA et al. |
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain. |
2011 |
Pharmacol. Res. |
pmid:21440630
|
Bakas T et al. |
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA receptors. |
2017 |
Pharmacol. Res. |
pmid:28249817
|
Pagano E et al. |
Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis. |
2017 |
Pharmacol. Res. |
pmid:28193521
|
Straiker A et al. |
Aiming for allosterism: Evaluation of allosteric modulators of CB1 in a neuronal model. |
2015 |
Pharmacol. Res. |
pmid:26211948
|
Imperatore R et al. |
Formation of OX-1R/CB1R heteromeric complexes in embryonic mouse hypothalamic cells: Effect on intracellular calcium, 2-arachidonoyl-glycerol biosynthesis and ERK phosphorylation. |
2016 |
Pharmacol. Res. |
pmid:27436148
|